Product Images Agamree
View Photos of Packaging, Labels & Appearance
- Structural Formula - aga01 0000 01
- Figure 1 - aga01 0000 02
- Figure - aga01 0000 03
- Figure - aga01 0000 04
- Figure - aga01 0000 05
- Figure - aga01 0000 06
- Figure - aga01 0000 07
- Figure - aga01 0000 08
- Figure - aga01 0000 09
- Figure - aga01 0000 10
- Figure - aga01 0000 11
- Figure - aga01 0000 12
- Figure - aga01 0000 13
- Figure - aga01 0000 14
- Figure - aga01 0000 15
- Principal Display Panel – 100 mL Carton Label - aga01 0000 16
- Principal Display Panel – 100 mL Carton Label - aga01 0000 17
Product Label Images
The following 17 images provide visual information about the product associated with Agamree NDC 69616-264 by Catalyst Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Structural Formula - aga01 0000 01
Figure 1 - aga01 0000 02
Figure - aga01 0000 03
Figure - aga01 0000 04
Figure - aga01 0000 05
Figure - aga01 0000 06
Figure - aga01 0000 07
Figure - aga01 0000 08
Figure - aga01 0000 09
Figure - aga01 0000 10
Figure - aga01 0000 11
Figure - aga01 0000 12
Figure - aga01 0000 13
Figure - aga01 0000 14
Figure - aga01 0000 15
Principal Display Panel – 100 mL Carton Label - aga01 0000 16
Principal Display Panel – 100 mL Carton Label - aga01 0000 17
This text provides information about a medication called vamorolone, which is available in a 100 mL oral suspension. Each mL of the suspension contains 40 mg of vamorolone. The recommended dosage and administration instructions are not provided in the text, and it suggests referring to the prescribing information for more details. The medication should be stored at room temperature, between 68°F to 77°F (20°C to 25°C). Before each use, the bottle should be shaken well for 30 seconds. Once opened, the oral suspension should be tightly closed and kept refrigerated. Any unused oral suspension remaining after 3 months of opening the bottle should be discarded. The medication is manufactured in Italy for Catalyst Pharmaceuticals, Inc. located in Coral Gables, FL 33134.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
